Previously, Hampson et al. (2006) attempted to answer these questions by examining whether the wild-type p53 that accumulates in cervical cancer cells after treatment with lopinavir is functional by examining the expression of the p53-transactivated gene, p21. The gene discussed is TP53; the disease is cervical cancer.